公开(公告)号：US20180264122A1

公开(公告)日：2018-09-20

申请号：US15762180

申请日：2016-09-22

申请人： Vitality Biopharma, Inc

发明人： Brandon J. Zipp ,  Janee M. Hardman ,  Robert T. Brooke

IPC分类号： A61K47/54 ,  A61K31/352

CPC分类号： A61K47/549 ,  A61K9/0014 ,  A61K9/0019 ,  A61K9/0053 ,  A61K31/352 ,  A61K31/7012 ,  A61K31/7016 ,  A61K31/7034 ,  A61P1/10 ,  A61P25/00 ,  A61P29/00 ,  C07H15/10 ,  C07H15/203

摘要： The present invention relates to cannabinoid glycoside prodrugs suitable for site- and tissue-specific delivery of cannabinoid molecules. The present invention also relates to methods of forming the cannabinoid glycoside prodrugs through glycosyltransferase mediated glycosylation of cannabinoid molecules.